Mucosal Melanoma

I wish I was there. I’m so bummed I couldn’t come this year but will do everything I can to make it next year and every year after. Thank you so much @KyleighMrf , @CureMelanoma and @ASCO for everthing you do! From #mucosalmelanomasurvivor and all of #mucosalmelanoma (@MucosalMelanoma)

Happening now @ASCO the @CureMelanoma Breakthrough Consortium meeting with @gmboland MRF funded researcher presenting on a mucosal #melanoma translational program which will hopefully lead to better outcomes for patients. #research #ASCO2023 (@KyleighMrf)

Thank you! You too! ❤️ we should chat mucosal melanoma sometime soon; as mutations in fucosylation machinery have been reported to track with mucosal tissues! (@EricLauLab)

#mucosal #melanoma : #eIF4F translation initiation complex, predictive of response to #immunotherapy https://t.co/xIkQf7e0rP (@GorphePhilippe)

We need better treatments for acral and mucosal #melanoma, known to be less likely to respond to existing immunotherapy approaches. Dr. Lu Si presents PD-1/VEGFR-2 TKI/temozolomide triplet data in a single-arm, single-center study of patients with acral melanoma from China. (@EvanHallMD)

Congratulations! Very interesting study. There is an urgent need to make ICIs and BRAF/MEKi accessible in LMIC, and to develop effective strategies to treat mucosal melanomas. It reminded me of the public health system in Brazil, where we essentially have chemo only. (@MunizThiago)

Interest in IL-2 for oncology really fell off. $ALKS nemvaleukin reported single agent activity & plan monotherapy registration trial in mucosal melanoma but everyone yawned. $RHHBY made splash with RO6874281 (FAP-IL2v) single agent activity too, rarely ever mentioned it lately. (@jq1234t)

Mucosal melanoma of oesophagus which rarely have BRAF mutation Rare case Thank you Dr Tristan 👍 (@anjuthevirgo)